Skip to main content
. 2016 Feb 24;34(9):1215–1224. doi: 10.1016/j.vaccine.2015.12.021

Table 1.

Relevant stimulatory peptides mapped in cultured IFN-γ ELISPOT assay in HIV-CORE 002 (modified from Ref. [22]).

Peptide
Volunteer no.
No. HXB2 aa position Sequence 411 418 421
3 Gag 166-171 EVIPMFTALSEGATP 1200a
17 Gag 268-282 GLNKIVRMYSPVSIL 1583 517
31 Gag 426-440 CTERQANFLGKIWPS 683
47 Pol 154-168 LTQIGCTLNFPISPI 600
49 Pol 165-179 KNFPISPIETVPVKLKb 883
67 Pol 226/227-240 W-RKLVDFRELNKRTQc 483
78 Pol 270-284 YFSVPLDEGFRKYTA 2367
80 Pol 277-293 GFRKYTAFTIPSINN 1917 667
88 Pol 311-325 GSPAIFQSSMTKILE 750 2017
90 Pol 319-333 SMTKILEPFRAQNPE
93 Pol 331-345 KNPEIVIYQYMDDLYVb 3967 4133 650
94 Pol 335-349 VIYQYMDDLYVGSDL 750 1300
116 Pol 563-577 ATWIPEWEFVNTPPL 617
117 Pol 567-581 PEWEFVNTPPLVKLW 1283
135 Pol 706-720 KLVSQGIRKVLFLDG 2050
164 Pol 891-906 VQMAVFIHNFKRKGGI 517
175 Pol 970-984 SDIKVVPRRKAKIIR 700
a

Numbers indicate cultured IFN-γ ELISPOT assay frequencies as SFU/106 PBMCs [22].

b

Underlined K indicates lysine added to improve peptide solubility.

c

‘–’ dash in peptide sequence indicates junction between adjacent conserved regions.